Iconiq Capital’s Enfusion, Inc. ENFN Stock Holding History

Iconiq Capital’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14,039,594	Closed	-$157M	–	460
2025 Q1	$157M	Hold	14,039,594	–	–	2.78%	8
2024 Q4	$145M	Hold	14,039,594	–	–	2.25%	8
2024 Q3	$133M	Hold	14,039,594	–	–	2.86%	7
2024 Q2	$120M	Hold	14,039,594	–	–	2.56%	7
2024 Q1	$130M	Hold	14,039,594	–	–	2.26%	8
2023 Q4	$136M	Hold	14,039,594	–	–	2.54%	8
2023 Q3	$126M	Hold	14,039,594	–	–	2.48%	8
2023 Q2	$158M	Hold	14,039,594	–	–	2.64%	8
2023 Q1	$147M	Hold	14,039,594	–	–	2.24%	8
2022 Q4	$136M	Hold	14,039,594	–	–	2%	9
2022 Q3	$173M	Hold	14,039,594	–	–	2.14%	7
2022 Q2	$143M	Hold	14,039,594	–	–	1.7%	9
2022 Q1	$179M	Hold	14,039,594	–	–	1.32%	10
2021 Q4	$294M	Buy	+14,039,594	New	+$284M	1.76%	8

Other funds holding ENFN

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Iconiq Capital's ENFN Position: Q2 2025 in Review

Iconiq Capital sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 14,039,594 shares — an estimated $157M sold.

Iconiq Capital first reported a position in ENFN in Q4 2021 and held it in 14 quarters. The position peaked at $294M in Q4 2021. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

Iconiq Capital reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
Iconiq Capital sold 14,039,594 Enfusion, Inc. shares in Q2 2025, an estimated $157M.
Iconiq Capital first reported a position in Enfusion, Inc. in Q4 2021 and held it in 14 quarters.
Iconiq Capital's Enfusion, Inc. position peaked at $294M in Q4 2021.
2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Iconiq Capital's 13F filing for Q2 2025, filed 14 Aug 2025.